Palo Alto, California – November 8, 2023 – LVIS Corporation, a leading innovator in healthcare technology, is thrilled to announce its participation in the upcoming 2023 American Epilepsy Society (AES) Meeting in Orlando, Florida, from December 1 to 5. The company will introduce its groundbreaking new product, NeuroMatch®, designed to help epilepsy specialists gain insights and understanding of brain networks in patients that suffer from epilepsy. NeuroMatch represents a significant advancement for LVIS in offering doctors and healthcare professionals a state-of-the-art tool to enhance their ability to diagnose and treat patients with epilepsy.
AES Event Details:
Date: December 1-5, 2023
Location: Orlando, Florida
Booth Number: 1421
David Cash, Chief Executive Officer at LVIS Corporation, stated, “NeuroMatch is a game-changer in epilepsy care. It provides a highly accessible and secure software suite of tools to reveal and animate brain networking patterns in 3D. We are excited to engage with healthcare professionals at the 2023 American Epilepsy Society.” Doctors, researchers, and medical professionals attending the conference are encouraged to visit LVIS Corporation’s booth number 1421 to learn more.
For more information about LVIS Corporation and NeuroMatch, please visit our website at www.lviscorp.com or contact us at contact@lviscorp.com.
About LVIS Corporation:
LVIS Corporation, headquartered in Palo Alto, California, is a pioneering healthcare technology company dedicated to improving patient care and outcomes. With a strong focus on innovation and cutting-edge technologies, LVIS Corporation strives to develop solutions that make a significant difference in brain healthcare.